» Articles » PMID: 30962877

Manual Therapy for Chronic Migraine: a Pragmatic Randomised Controlled Trial Study Protocol

Overview
Publisher Biomed Central
Date 2019 Apr 10
PMID 30962877
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Chronic migraine is a largely refractory condition affecting between 1 and 2.2% of the overall population worldwide, with females more affected than males. There are also high health and socioeconomic costs associated both for the individual and society. The mainstay of chronic migraine management is pharmacological, but the options available have limited efficacy and there are often unwanted side effects. There is some evidence for manual therapy as a treatment option for migraine, but its effectiveness for chronic migraine is unknown. Therefore, we have designed a pragmatic randomised control trial to investigate whether adding manual therapy to the tertiary specialist treatment of chronic migraine improves patient-reported outcomes.

Methods: A pragmatic, randomised controlled trial in a hospital tertiary headache clinic Participants will be randomised into one of two groups: treatment as usual or treatment as usual plus manual therapy. The primary outcome measure will be a change in the Headache Impact Test score. Secondary outcomes will also be measured over the 12-week study period including changes in headache frequency, migraine specific quality of life and reductions in relevant medicine consumption. The manual therapy group will have five treatment sessions each lasting 30 min. The recruitment target of 64 participants will allow power at 80% with  = 0.05 using minimal clinical difference for Headache Impact Test of 3.7 and includes provision for a 10% dropout rate. Recruitment will take place between August 2018 and February 2019. The results will form part of a doctoral study and be published in peer-reviewed journals and presented at national/international conferences.

Discussion: Current pharmacological approaches have limited effects in the management of chronic migraine and there is a requirement to improve treatment options and reduce the health and economic burden of the condition. Manual therapy has been shown to be effective in other chronic pain conditions as well as other primary headaches. This study will explore the effectiveness of manual therapy as an adjunctive approach to the management of chronic migraine.

Trial Registration: The trial has received a favourable opinion from the UK Health Research Authority (IRAS 228901) and is registered at ClinicalTrials.gov.number NCT03395457. Registered 1st March 2018.

Citing Articles

Exploring Adherence to Pelvic Floor Muscle Training in Women Using Mobile Apps: Scoping Review.

Harper R, Sheppard S, Stewart C, Clark C JMIR Mhealth Uhealth. 2023; 11:e45947.

PMID: 38032694 PMC: 10722367. DOI: 10.2196/45947.


Primary headache management in a multidisciplinary team - a pilot study.

Mihaiu J, Debucean D, Mihancea P, Maghiar A, Marcu O J Med Life. 2023; 16(7):1127-1135.

PMID: 37900070 PMC: 10600663. DOI: 10.25122/jml-2023-0259.


Successful management of chronic migraine through manual therapy. A case report.

Mihaiu J, Bodog F, Mohan A, Vieriu G J Med Life. 2023; 16(6):953-956.

PMID: 37675175 PMC: 10478666. DOI: 10.25122/jml-2023-0222.


Levels and determinants of knowledge about chronic migraine diagnosis and management among primary health-care physicians in ministry of health, Jeddah 2019.

Aljunaid M, Jamal H, Mubarak A, Bardisi W J Family Med Prim Care. 2020; 9(5):2324-2331.

PMID: 32754496 PMC: 7380749. DOI: 10.4103/jfmpc.jfmpc_266_20.


Letter to the editor, Odell 2019.

Tuchin P Chiropr Man Therap. 2019; 27:52.

PMID: 31452872 PMC: 6700790. DOI: 10.1186/s12998-019-0271-x.

References
1.
Galego J, Cipullo J, Cordeiro J, Tognola W . Clinical features of episodic migraine and transformed migraine: a comparative study. Arq Neuropsiquiatr. 2003; 60(4):912-6. DOI: 10.1590/s0004-282x2002000600005. View

2.
Nijs J, Meeus M, Van Oosterwijck J, Roussel N, De Kooning M, Ickmans K . Treatment of central sensitization in patients with 'unexplained' chronic pain: what options do we have?. Expert Opin Pharmacother. 2011; 12(7):1087-98. DOI: 10.1517/14656566.2011.547475. View

3.
Zappaterra M, Guerzoni S, Cainazzo M, Ferrari A, Pini L . Basal cutaneous pain threshold in headache patients. J Headache Pain. 2011; 12(3):303-10. PMC: 3094665. DOI: 10.1007/s10194-011-0313-9. View

4.
Negro A, Curto M, Lionetto L, Crialesi D, Martelletti P . OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study. Springerplus. 2016; 4:826. PMC: 4695480. DOI: 10.1186/s40064-015-1636-9. View

5.
Borsook D, Maleki N, Becerra L, McEwen B . Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron. 2012; 73(2):219-34. DOI: 10.1016/j.neuron.2012.01.001. View